The European Medicines Agency’s Committee for Medicinal Products for Human Use has put 10 medicines forward for approval in the region, including new options for multiple sclerosis, eosinophilic esophagitis and eosinophilic asthma. More: Ten new medicines leap towards EU approval
read moreBritish venture the Dementia Discovery Fund (DDF) has received a $50 million investment from Bill Gates, to help fuel progress toward disease-modifying therapies for Alzheimer’s disease. More: Gates streams m into Britain’s Dementia Discovery Fund Source: News
read moreWith everyone wondering if Amazon is going to jump whole-hog into selling medication over the internet, it was inevitable that CEO John Hendrickson would be asked what the implications are for Perrigo. And his assessment is that in the OTC
read moreStill dealing with intense pricing pressure in its key diabetes business, Novo Nordisk is embarking on its latest wave of job cuts. More: Novo Nordisk cutting 185 jobs, adding another 70 in commercial revamp Source: fierce
read moreCost watchdogs in England and pharma don’t always see eye to eye, but the sides are celebrating two new deals on Merck KGaA’s Mavenclad and Roche’s Perjeta. More: Merck KGaA's Mavenclad, Roche's Perjeta win 'innovative' coverage deals with NHS Source:
read moreAstraZeneca CEO Pascal Soriot committed to paying a generous dividend “today, tomorrow, and thereafter,” during yesterday’s earnings call. But investors can be tough on pharma companies when they fail to live up to such vows, and AZ will face some
read more© 1994 - 2026 B.M. Pharmaceuticals